101 related articles for article (PubMed ID: 23224964)
1. Autoantibodies to Argonaute 2 (Su antigen).
Satoh M; Chan JY; Ceribelli A; Vazquez del-Mercado M; Chan EK
Adv Exp Med Biol; 2013; 768():45-59. PubMed ID: 23224964
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to a miRNA-binding protein Argonaute2 (Su antigen) in patients with hepatitis C virus infection.
Vázquez-Del Mercado M; Sánchez-Orozco LV; Pauley BA; Chan JY; Chan EK; Panduro A; Maldonado González M; Jiménez-Luévanos MA; Martín-Márquez BT; Palafox-Sánchez CA; Dávalos-Rodríguez IP; Salazar-Páramo M; González-López L; Gámez-Nava JI; Satoh M
Clin Exp Rheumatol; 2010; 28(6):842-8. PubMed ID: 21122261
[TBL] [Abstract][Full Text] [Related]
3. Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS).
Ceribelli A; Tincani A; Cavazzana I; Franceschini F; Cattaneo R; Pauley BA; Chan JY; Chan EK; Satoh M
Autoimmunity; 2011 Mar; 44(2):90-7. PubMed ID: 20695766
[TBL] [Abstract][Full Text] [Related]
4. An SNP in the trinucleotide repeat region of the TNRC6A gene maps to a major TNGW1 autoepitope in patients with autoantibodies to GW182.
Moser JJ; Chan EK; Fritzler MJ
Adv Exp Med Biol; 2013; 768():243-59. PubMed ID: 23224974
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Su antigen, a macromolecular complex of 100/102 and 200-kDa proteins recognized by autoantibodies in systemic rheumatic diseases.
Satoh M; Langdon JJ; Chou CH; McCauliffe DP; Treadwell EL; Ogasawara T; Hirakata M; Suwa A; Cohen PL; Eisenberg RA
Clin Immunol Immunopathol; 1994 Oct; 73(1):132-41. PubMed ID: 7923910
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune targeting of key components of RNA interference.
Jakymiw A; Ikeda K; Fritzler MJ; Reeves WH; Satoh M; Chan EK
Arthritis Res Ther; 2006; 8(4):R87. PubMed ID: 16684366
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to Su/Argonaute 2 in Japanese patients with inflammatory myopathy.
Ogawa-Momohara M; Muro Y; Satoh M; Akiyama M
Clin Chim Acta; 2017 Aug; 471():304-307. PubMed ID: 28673815
[TBL] [Abstract][Full Text] [Related]
8. Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study.
Vázquez-Del Mercado M; Martínez-García EA; Daneri-Navarro A; Gómez-Bañuelos E; Martín-Márquez BT; Pizano-Martínez O; Wilson-Manríquez EA; Corona-Sánchez EG; Chavarria-Avila E; Sandoval-García F; Satoh M
Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):328-333. PubMed ID: 33876712
[TBL] [Abstract][Full Text] [Related]
9. Clinical and serological features of patients with autoantibodies to GW/P bodies.
Bhanji RA; Eystathioy T; Chan EK; Bloch DB; Fritzler MJ
Clin Immunol; 2007 Dec; 125(3):247-56. PubMed ID: 17870671
[TBL] [Abstract][Full Text] [Related]
10. Introduction: the GW body story as an example of autoantibodies with significant impacts to molecular cell biology.
Chan EK; Fritzler MJ
Adv Exp Med Biol; 2013; 768():1-4. PubMed ID: 23224961
[No Abstract] [Full Text] [Related]
11. GW/P-bodies and autoimmune disease.
Bloch DB; Nobre RA; Yang WH
Adv Exp Med Biol; 2013; 768():61-70. PubMed ID: 23224965
[TBL] [Abstract][Full Text] [Related]
12. Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera.
Satoh M; Treadwell EL; Reeves WH
J Immunol Methods; 1995 May; 182(1):51-62. PubMed ID: 7769244
[TBL] [Abstract][Full Text] [Related]
13. Bio-functional surfaces for the immunocapture of AGO2-bound microRNAs.
Vaghi V; Potrich C; Lunelli L; Facci P; Pasquardini L; Vanzetti L; Pederzolli C
Colloids Surf B Biointerfaces; 2016 Oct; 146():746-53. PubMed ID: 27449965
[TBL] [Abstract][Full Text] [Related]
14. Reflections on ten years of history of, and future prospects for, GW182 and GW/P body research.
Chan EK; Yao B; Fritzler MJ
Adv Exp Med Biol; 2013; 768():261-70. PubMed ID: 23224975
[No Abstract] [Full Text] [Related]
15. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
Nakamura RM; Tan EM
Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
[TBL] [Abstract][Full Text] [Related]
16. The RNA interference pathway: a new target for autoimmunity.
Pruijn GJ
Arthritis Res Ther; 2006; 8(4):110. PubMed ID: 16805905
[TBL] [Abstract][Full Text] [Related]
17. Argonaute 2 immunoprecipitation revealed large tumor suppressor kinase 1 as a novel proapoptotic target of miR-21 in T cells.
Teteloshvili N; Smigielska-Czepiel K; Yuan Y; Seitz A; de Jong D; Rutgers B; Jellema P; van der Lei RJ; Slezak-Prochazka I; Brouwer E; Boots AM; Kroesen BJ; van den Berg A; Kluiver J
FEBS J; 2017 Feb; 284(4):555-567. PubMed ID: 28075055
[TBL] [Abstract][Full Text] [Related]
18. Identifying RISC Components Using Ago2 Immunoprecipitation and Mass Spectrometry.
Yi T
Methods Mol Biol; 2018; 1720():149-159. PubMed ID: 29236257
[TBL] [Abstract][Full Text] [Related]
19. PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma.
Zhang H; Sheng C; Yin Y; Wen S; Yang G; Cheng Z; Zhu Q
Cancer Lett; 2015 Oct; 367(1):49-57. PubMed ID: 26188282
[TBL] [Abstract][Full Text] [Related]
20. The immunology of rheumatoid diseases.
Koffler D
Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
